Minde Zeng

1.2k total citations
23 papers, 729 citations indexed

About

Minde Zeng is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Minde Zeng has authored 23 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 15 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Minde Zeng's work include Liver Disease Diagnosis and Treatment (16 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (8 papers). Minde Zeng is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (8 papers). Minde Zeng collaborates with scholars based in China, United Kingdom and United States. Minde Zeng's co-authors include Yimin Mao, Lungen Lu, Chunfang Gao, Jiyao Wang, Jiqiang Li, Xia-qiu Zhou, Xiong Cai, Cheng‐Wei Chen, Jinlin Hou and Xiaoyu Chen and has published in prestigious journals such as PLoS ONE, Hepatology and World Journal of Gastroenterology.

In The Last Decade

Minde Zeng

22 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minde Zeng China 14 565 480 91 72 48 23 729
Hiroaki Yamagami Japan 12 425 0.8× 297 0.6× 104 1.1× 52 0.7× 72 1.5× 44 680
Kazushige Nirei Japan 12 440 0.8× 302 0.6× 122 1.3× 52 0.7× 41 0.9× 39 685
Fa‐Yauh Lee Taiwan 9 515 0.9× 519 1.1× 92 1.0× 68 0.9× 154 3.2× 15 713
B. Kutala France 4 370 0.7× 328 0.7× 91 1.0× 48 0.7× 92 1.9× 7 530
Gady G Katz Canada 13 327 0.6× 303 0.6× 107 1.2× 83 1.2× 48 1.0× 19 622
Seren Özeni̇rler Türkiye 18 473 0.8× 326 0.7× 116 1.3× 43 0.6× 116 2.4× 51 762
Rei‐Hwa Lu Taiwan 12 437 0.8× 421 0.9× 103 1.1× 43 0.6× 125 2.6× 22 678
Sylvie Grimbert France 11 387 0.7× 312 0.7× 159 1.7× 51 0.7× 74 1.5× 18 704
Masako Shiba Japan 7 386 0.7× 377 0.8× 146 1.6× 126 1.8× 90 1.9× 9 679
Edmund Purucker Germany 11 407 0.7× 428 0.9× 60 0.7× 133 1.8× 148 3.1× 17 691

Countries citing papers authored by Minde Zeng

Since Specialization
Citations

This map shows the geographic impact of Minde Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minde Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minde Zeng more than expected).

Fields of papers citing papers by Minde Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minde Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minde Zeng. The network helps show where Minde Zeng may publish in the future.

Co-authorship network of co-authors of Minde Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Minde Zeng. A scholar is included among the top collaborators of Minde Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minde Zeng. Minde Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hongzhong, Tao Liu, Yingxuan Chen, et al.. (2024). Pharmacokinetics, pharmacodynamics and safety of 15 mg-tolvaptan administered orally for 7 consecutive days to Chinese patients with child-Pugh B cirrhosis. Frontiers in Pharmacology. 15. 1324299–1324299.
2.
Lei, Xiaohong, Qingling Xu, Jing Li, et al.. (2021). Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison. Journal of International Medical Research. 49(8). 3619100738–3619100738. 11 indexed citations
3.
Tang, Jieting, Yongfeng Wang, Tao Han, et al.. (2020). Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial. BMC Gastroenterology. 20(1). 391–391. 6 indexed citations
4.
Wang, Yongfeng, Zhenghua Wang, Mengqiu Gao, et al.. (2019). Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug‐induced liver injury: A phase II trial. Liver International. 39(11). 2102–2111. 39 indexed citations
5.
Liu, Xiaolin, Yanan Ming, Jingyi Zhang, et al.. (2017). Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes. Experimental & Molecular Medicine. 49(1). e283–e283. 27 indexed citations
6.
Liu, Xiaolin, Yongfeng Wang, Yanan Ming, et al.. (2015). S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis. PLoS ONE. 10(5). e0127352–e0127352. 25 indexed citations
7.
Hou, Jinlin, Huiguo Ding, Guofeng Chen, et al.. (2015). Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B. PLoS ONE. 10(12). e0144425–e0144425. 22 indexed citations
8.
Zhang, Jingyi, et al.. (2015). The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus. Scandinavian Journal of Gastroenterology. 50(9). 1152–1159. 14 indexed citations
9.
Zeng, Minde, Yimin Mao, Hao Wang, et al.. (2011). Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg‐positive chronic hepatitis B. Liver International. 32(1). 137–146. 21 indexed citations
10.
Zhou, Kun, Chunfang Gao, Yunpeng Zhao, et al.. (2010). Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology. 25(9). 1569–1577. 96 indexed citations
11.
Xi, Zhifeng, Zhuping Fan, Dekai Qiu, & Minde Zeng. (2009). The relationship between fatty liver disease and liver metastases from colorectal cancer. Zhonghua xiaohua zazhi. 29(3). 157–160. 2 indexed citations
12.
Shen, Min, et al.. (2007). Phase I Safety and Pharmacokinetic Study of Magnesium Isoglycyrrhizinate After Single and Multiple Intravenous Doses in Chinese Healthy Volunteers. The Journal of Clinical Pharmacology. 47(6). 767–773. 21 indexed citations
13.
Ma, Xiong, et al.. (2007). [Assessment of the health-related quality of life of patients with minimal hepatic encephalopathy].. PubMed. 15(6). 412–6. 1 indexed citations
14.
Zeng, Minde, Yimin Mao, Hao Wang, et al.. (2006). A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B. Hepatology. 44(1). 108–116. 60 indexed citations
15.
Zeng, Minde, Lungen Lu, Yimin Mao, et al.. (2005). Prediction of significant fibrosis in HBeAg‐positive patients with chronic hepatitis B by a noninvasive model†. Hepatology. 42(6). 1437–1445. 139 indexed citations
16.
Zeng, Minde. (2003). Stress on research of nonalcoholic fatty liver disease. 1 indexed citations
17.
Lu, Lungen, Minde Zeng, Yimin Mao, et al.. (2003). Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial. World Journal of Gastroenterology. 9(11). 2480–2480. 69 indexed citations
18.
Lu, Lungen, Minde Zeng, Mobin Wan, et al.. (2003). Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters. World Journal of Gastroenterology. 9(11). 2574–2574. 66 indexed citations
19.
Yang, Wenzhuo, Minde Zeng, Yimin Mao, et al.. (2002). [Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis].. PubMed. 10(3). 193–6. 21 indexed citations
20.
Fan, Jian‐Gao, et al.. (2001). Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver. World Journal of Gastroenterology. 7(5). 710–710. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroaki Yamagami Breakdown of academic impact, for papers by Kazushige Nirei Breakdown of academic impact, for papers by Fa‐Yauh Lee Breakdown of academic impact, for papers by B. Kutala Breakdown of academic impact, for papers by Gady G Katz Breakdown of academic impact, for papers by Seren Özeni̇rler Breakdown of academic impact, for papers by Rei‐Hwa Lu Breakdown of academic impact, for papers by Sylvie Grimbert Breakdown of academic impact, for papers by Masako Shiba Breakdown of academic impact, for papers by Edmund Purucker
Rankless by CCL
2026